In this study, by conducting clustering consensus analysis using the biomarkers of CAFs, we found that FGF7 is highly expressed in CAF-high ccRCC patients as compared to CAF-low cohorts. The gene discussed is FGF7; the disease is nonpapillary renal cell carcinoma.